Unknown

Dataset Information

0

Midterm Degeneration of Transcatheter Heart Valve Device following Valve-in-Valve Transcatheter Aortic Valve Replacement Requiring Repeat Transcatheter Aortic Valve Replacement


ABSTRACT: Graphical abstract Highlights • ViV-TAVR is an alternative to redo-SAVR in patients with a degenerate surgical bioprosthesis.• Optimal TAVR device positioning is crucial in determining procedural durability.• TAVR-in-TAVR can be performed to treat a degenerated ViV-TAVR device.• Coronary obstruction, limited coronary access, and device thrombosis may occur.

SUBMITTER: Duncan A 

PROVIDER: S-EPMC7451866 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4862065 | biostudies-other
| S-EPMC4382556 | biostudies-literature
| S-EPMC4391320 | biostudies-other
| S-EPMC5876149 | biostudies-literature
| S-EPMC6140353 | biostudies-literature